Corneal cross-linking for ectasia started in 1998 with the «Dresden Protocol» for epi-off CXL. The video features Prof. Frederik Raiskup from the University Eye Clinic Dresden who explains the origins of the “Dresden Protocol”, currently Protocol 1 in the C-Eye device .
Ever since the discovery of oxygen as an essential element in the CXL process by Farhad Hafezi’s research group at the University of Zurich, the field has developed substantially: accelerated protocols have been developed to save on treatment time, transepithelial approaches preserve the epithelium, and pulsed treatment help improve oxygen availability.
For a complete overview of the protocols, see the 2nd edition of the most complete textbook on corneal cross-linking to date:
EMAGine's CEO Nikki Hafezi, a “Top 40 under 40” PowerList awardee, tells how innovation and perseverance allowed her to successfully establish the C-Eye device (corneal cross-linking at the slit lamp) in the midst of the COVID-19 crisis. The C-Eye device is seen by many as a game changer in keratoconus treatment.
See here an introduction video to the C-Eye device and Ribo-Ker, EMAGine’s riboflavin solution. The device enables the ophthalmologist to treat keratoconus and corneal infections at the slit lamp. EMAGine the possibilities. #ophthalmology #innovation #keratoconus #keratitis #cornea vimeo.com/517046984... See MoreSee Less
Another successful clinical study on the effect of PACK-CXL on infectious keratitis from Dr. Rosario Gulias-Cañizo from Mexico:. The body of evidence is steadily increasing, see here: pubmed.ncbi.nlm.nih.gov/33376299/ #cornealulcer #keratitis #CornealCrossLinking #cornea ... See MoreSee Less